Understanding the Consequences of Recreational Noise Exposure
NCT ID: NCT05076344
Last Updated: 2025-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2022-05-19
2025-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Use of Hearing Protection Equipment in the Occurence of Acute Acoustic Trauma in the Army
NCT04804982
High Frequency ABR
NCT06161857
Exposure to Intense and Prolonged Noises During Pregnancy
NCT05911204
Study of Diagnostic Biomarkers of Acute Acoustic Trauma
NCT04832230
Impact of Earplugs on Mechanisms of Noise-Related Cardiovascular Disease
NCT07148817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hearing loss is usually diagnosed using pure tone audiometry, which measures the sensitivity of the ear to quiet sounds by determining the levels of tones that can just be heard at several test frequencies. Until recently, it had been assumed that hearing loss results mainly from damage to the sensory hair cells in the cochlea, the part of the ear that converts acoustic vibrations into electrical impulses in the cochlear nerve (CN). However, recent results from animal studies suggest that even moderate noise exposure can cause substantial damage to the CN, without any noticeable damage to the hair cells. Crucially, these results suggest that such damage does not immediately affect sensitivity to quiet sounds, but may exacerbate the effects of ageing.
Hearing loss is a huge problem. Substantial numbers of people, millions in the United Kingdom (UK) alone, are routinely exposed to significant levels of occupational and/or recreational noise. A large UK study found that one in seven adults aged 17-30 years reported "great difficulty" hearing speech in noisy backgrounds, while only one in fifty had impaired sensitivity as measured by pure tone audiometry. Hearing loss can lead to social isolation, depression, and is likely to be predictive of more severe hearing loss in old age. Recent studies suggest that hearing loss also reduces quality of life and is a risk factor for dementia.
This study is part of a programme grant conducted from April 2021 to March 2026 by The University of Manchester and The University of Nottingham. The overall aim of the programme is to understand the consequences of recreational noise exposure through improvement of the understanding of the contribution of CN damage to listening difficulties and audiometric losses.
The primary research questions are:
1. How does auditory pathway integrity vary with noise exposure, audiometric / outer hair cell (OHC) loss, and age?
2. How do auditory pathway integrity, audiometric loss, and OHC loss relate to listening difficulties? The secondary research question is to address how MRI measures relate to electrophysiological measures of auditory pathway integrity.
All participants will undergo the following non-invasive examinations:
* Extended high frequency audiometry to 16 kHz.
* Distortion Product Otoacoustic Emissions (DPOAEs): DPOAEs to 10.5 kHz.
* Middle Ear Muscle Reflex (MEMR): using a broadband contralateral elicitor and a click probe.
* Auditory Brainstem Response (ABR) to assess cochlear synaptopathy and central neural function. The ABR will be elicited with high-pass clicks.
* Speech in noise: A masked speech test will comprise verbal stimuli presented through headphones. The signal-to-background ratio will be varied adaptively to determine reception threshold.
* The Auditory Digit Span test to assess both forward and backward recall as a measurement of short term memory and working memory.
* The Tinnitus Functional Index to assess the severity of tinnitus.
* The Noise Exposure Structured Interview (NESI) to assess the lifetime noise exposure.
* MR Neurography using structural Magnetic Resonance Imaging to visualise the cochlear nerve and measure the diameter/cross-sectional area.
* High-resolution diffusion tensor imaging (DTI) to determine the apparent diffusion coefficient (ADC) and fractional anisotropy (FA) in the cochlear nerve.
* Whole-brain DTI to measure the apparent diffusion coefficient (ADC) and fractional anisotropy (FA) in the ascending auditory pathway and auditory cortex.
* High spatial resolution quantitative T1 mapping will be used to assess myelination in the ascending auditory pathway and auditory cortex.
* High spatial resolution T1 weighted imaging will be used to assess morphometry in the ascending auditory pathway and auditory cortex.
* Resting State Functional MRI, lasting 15 minutes, with eyes open and relaxed fixation, will be used to assess the functional connectivity in the ascending auditory pathway and auditory cortex.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: young adults
50 adults aged 18-19 years, with low lifetime noise exposure and audiometric thresholds in the normal range for their age.
No interventions assigned to this group
Group 2: older adults with low noise exposure
50 adults aged 30-50 years, with low lifetime noise exposure and audiometric thresholds in the normal range for their age.
No interventions assigned to this group
Group 3: older adults with high noise exposure
50 adults aged 30-50 years, with high lifetime noise exposure and audiometric thresholds in the normal range for their age.
No interventions assigned to this group
Group 4: older adults with suspected noise-induced hearing loss
50 adults aged 30-50 years, with high lifetime noise exposure and audiometric thresholds above the normal range for their age.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In the age range stipulated for the group, i.e. 18-19 inclusive for group 1 and 30-50 inclusive for groups 2 - 4.
* Audiometric thresholds in the range stipulated for the group, i.e. in the normal range for their age group for groups 1 - 3 and outside the normal range for their age group for group 4.
* Noise exposure in the range stipulated for the group, as determined by the NESI, i.e. less than 15 units for groups 1 - 2 and 15 or more units for groups 3 - 4.
Exclusion Criteria
* Motor impairment (for example, cerebral palsy)
* Cognitive impairment (for example, dementia or brain injury)
* Health conditions indicative of peripheral neuropathy (e.g. Type 1 diabetes).
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manchester
OTHER
Nottingham University Hospitals NHS Trust
OTHER
National Institute for Health Research Nottingham Biomedical Research Centre
UNKNOWN
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan T Francis, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Nottingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hearing Theme, NIHR Nottingham Biomedical Research Centre, Ropewalk House, 113 The Ropewalk
Nottingham, Nottinghamshire, United Kingdom
Sir Peter Mansfield Imaging Centre, University of Nottingham
Nottingham, Nottinghamshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gates GA, Schmid P, Kujawa SG, Nam B, D'Agostino R. Longitudinal threshold changes in older men with audiometric notches. Hear Res. 2000 Mar;141(1-2):220-8. doi: 10.1016/s0378-5955(99)00223-3.
Kujawa SG, Liberman MC. Acceleration of age-related hearing loss by early noise exposure: evidence of a misspent youth. J Neurosci. 2006 Feb 15;26(7):2115-23. doi: 10.1523/JNEUROSCI.4985-05.2006.
Gopinath B, Schneider J, Rochtchina E, Leeder SR, Mitchell P. Association between age-related hearing loss and stroke in an older population. Stroke. 2009 Apr;40(4):1496-8. doi: 10.1161/STROKEAHA.108.535682. Epub 2009 Feb 26.
Deal JA, Albert MS, Arnold M, Bangdiwala SI, Chisolm T, Davis S, Eddins A, Glynn NW, Goman AM, Minotti M, Mosley T, Rebok GW, Reed N, Rodgers E, Sanchez V, Sharrett AR, Coresh J, Lin FR. A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study. Alzheimers Dement (N Y). 2017 Jun 21;3(3):410-415. doi: 10.1016/j.trci.2017.06.003. eCollection 2017 Sep.
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimaki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30. No abstract available.
Guest H, Dewey RS, Plack CJ, Couth S, Prendergast G, Bakay W, Hall DA. The Noise Exposure Structured Interview (NESI): An Instrument for the Comprehensive Estimation of Lifetime Noise Exposure. Trends Hear. 2018 Jan-Dec;22:2331216518803213. doi: 10.1177/2331216518803213.
Meikle MB, Henry JA, Griest SE, Stewart BJ, Abrams HB, McArdle R, Myers PJ, Newman CW, Sandridge S, Turk DC, Folmer RL, Frederick EJ, House JW, Jacobson GP, Kinney SE, Martin WH, Nagler SM, Reich GE, Searchfield G, Sweetow R, Vernon JA. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear. 2012 Mar-Apr;33(2):153-76. doi: 10.1097/AUD.0b013e31822f67c0.
Li Y, Yang J, Liu J, Wu H. Restudy of malformations of the internal auditory meatus, cochlear nerve canal and cochlear nerve. Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1587-96. doi: 10.1007/s00405-014-2951-4. Epub 2014 Mar 6.
Yan F, Li J, Xian J, Wang Z, Mo L. The cochlear nerve canal and internal auditory canal in children with normal cochlea but cochlear nerve deficiency. Acta Radiol. 2013 Apr 1;54(3):292-8. doi: 10.1258/ar.2012.110596. Epub 2013 Jan 14.
Tahir E, Bajin MD, Atay G, Mocan BO, Sennaroglu L. Bony cochlear nerve canal and internal auditory canal measures predict cochlear nerve status. J Laryngol Otol. 2017 Aug;131(8):676-683. doi: 10.1017/S0022215117001141. Epub 2017 Jun 1.
van der Jagt MA, Brink WM, Versluis MJ, Steens SC, Briaire JJ, Webb AG, Frijns JH, Verbist BM. Visualization of human inner ear anatomy with high-resolution MR imaging at 7T: initial clinical assessment. AJNR Am J Neuroradiol. 2015 Feb;36(2):378-83. doi: 10.3174/ajnr.A4084. Epub 2014 Aug 21.
Peng L, Xiao Y, Liu L, Mao Z, Chen Q, Zhou L, Liao B, Liu A, Wang X. Evaluation of cochlear nerve diameter and cross-sectional area in ANSD patients by 3.0-Tesla MRI. Acta Otolaryngol. 2016 Aug;136(8):792-9. doi: 10.3109/00016489.2016.1159329. Epub 2016 Mar 22.
Kasper JM, Wadhwa V, Scott KM, Rozen S, Xi Y, Chhabra A. SHINKEI--a novel 3D isotropic MR neurography technique: technical advantages over 3DIRTSE-based imaging. Eur Radiol. 2015 Jun;25(6):1672-7. doi: 10.1007/s00330-014-3552-8. Epub 2015 Feb 1.
Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage. 2012 Jul 16;61(4):1000-16. doi: 10.1016/j.neuroimage.2012.03.072. Epub 2012 Mar 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MR/V01272X/1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
295085
Identifier Type: OTHER
Identifier Source: secondary_id
21/LO/0615
Identifier Type: OTHER
Identifier Source: secondary_id
50341
Identifier Type: OTHER
Identifier Source: secondary_id
21021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.